title: Combination diuretic drug therapy.
mesh_terms: D000584:Amiloride / Q000627:therapeutic use; D001581:Benzothiadiazines; D004032:Diet; D004232:Diuretics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D005919:Glomerular Filtration Rate; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy; D006943:Hyperglycemia / Q000517:prevention & control; D006947:Hyperkalemia / Q000517:prevention & control; D007008:Hypokalemia / Q000517:prevention & control; D007010:Hyponatremia / Q000517:prevention & control; D007019:Hypoproteinemia / Q000517:prevention & control; D007668:Kidney / Q000098:blood supply; D008107:Liver Diseases / Q000188:drug therapy*; D009404:Nephrotic Syndrome / Q000188:drug therapy*; D009941:Organomercury Compounds / Q000627:therapeutic use; D012039:Regional Blood Flow; D012965:Sodium Chloride / Q000008:administration & dosage; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D014223:Triamterene / Q000627:therapeutic use
chemical_list: D001581:Benzothiadiazines; D004232:Diuretics; D009941:Organomercury Compounds; D049993:Sodium Chloride Symporter Inhibitors; D013148:Spironolactone; D012965:Sodium Chloride; D000584:Amiloride; D005665:Furosemide; D004976:Ethacrynic Acid; D014223:Triamterene